GeneDx Acquires Fabric Genomics for AI-Powered Testing at Global Scale; $WGS Down 1.9% Pre-Market

GeneDx has announced its acquisition of Fabric Genomics, a move aimed at enhancing decentralized, AI-powered testing capabilities on a global scale. This acquisition is expected to leverage advanced technologies to improve the efficiency and accessibility of genomic testing. The announcement follows a recent trend in the life sciences sector towards integrating artificial intelligence in healthcare solutions. The stock price of GeneDx was noted to be down 1.9% in pre-market trading following the announcement.